Better Quantum Computing Stock: D-Wave Quantum vs. Rigetti Computing

D-Wave, a leader in commercial quantum annealing with more than 100 paying customers and growing revenue and bookings, completed two at‑the‑market equity offerings in 2025 to fund the acquisition of Quantum Circuits and is combining dual‑rail technology to pursue error‑correcting gate‑based systems. Rigetti is pursuing a universal gate‑based approach with in‑house manufacturing and a modular architecture and claims systems over 1,000x faster than IonQ, but its 2‑gate fidelity (99.5%) lags competitors (IonQ ~99.99%), it recently delayed general availability of a 108‑qubit machine for fidelity reasons, has minimal revenue, and was not advanced to Stage B of DARPA’s QBI despite a three‑year U.S. Air Force contract and a partnership with Nvidia. The piece favors D‑Wave’s pragmatic annealing commercialization plus a measured move into gate‑based computing, while flagging Rigetti’s accuracy shortfalls as a material operational and competitive risk.

Analysis

Market structure: D-Wave (QBTS) benefits from a monetizable niche (quantum annealing) and the Quantum Circuits acquisition accelerates a plausible path to error-corrected gate systems; expect modest, repeatable revenue growth (mid-teens YoY bookings growth plausible near-term) rather than immediate TAM capture. Rigetti (RGTI) is the near-term loser: speed advantages don’t offset fidelity deficits (2‑gate fidelity 99.5% vs IonQ 99.99%), slowing commercial adoption and DARPA trajectory, compressing its pricing power and dilutive financing risk.

Risk assessment: Tail risks include a failed gate-based transition (technical flop), loss of defense contracts or export-control restrictions, and aggressive equity dilution — any of which could cut valuations by 50%+. Timeline: headline volatility in days, meaningful contract/fidelity news in 1–6 months, and commercial gate-scale viability over 2–5 years. Hidden dependencies include gov’t funding cadence, NVDA ecosystem adoption (NVQLink), and supply-chain continuity for chip fabs.

Trade implications: Implement asymmetric, event-driven trades: favor QBTS exposure financed by options or small-size equity, while using put spreads to short RGTI; use NVDA exposure as a hedge on NVQLink adoption via call spreads. Rotate modestly into higher-fidelity gate leaders (IONQ) and out of speculative pure-play hardware with <12 months runway; expect elevated implied volatility in options around DARPA/QBI and product GA dates.

Contrarian angles: The market underestimates annealing’s cash-flow runway and real-world optimization demand — QBTS could be acquisition bait if gate efforts stall elsewhere. Conversely, consensus downweighting of RGTI may be overdone if a fidelity breakthrough or government reprieve occurs; both scenarios create binary, high-Theta option trades and M&A upside that are underpriced today.

Key Decisions for Investors

• Establish a 2–3% long position in QBTS equity or buy 9–12 month QBTS call options (delta ~0.35–0.5) ahead of integration milestones from the Quantum Circuits deal; set a tactical stop-loss at -30% or exit if net cash runway falls below 12 months or if bookings growth stalls below 10% YoY on next report.
• Initiate a 1–2% short or buy a 3–6 month put spread on RGTI (cap loss via spread) targeting downside if fidelity issues persist; cover/trim if RGTI reports 2‑gate fidelity ≥99.9% or secures DARPA Stage B or comparable multi-year government contract.
• Put on a pair trade: long 1–2% IONQ (or equivalent call spread, 6–12 month) vs short 1% RGTI to capture relative fidelity/contract asymmetry; rebalance if the spread narrows <20% of current price difference or if IonQ’s reported fidelity falls below 99.9%.
• Add NVDA exposure via a 6–9 month call spread (buy 1, sell 1 at ~+15–25% strikes) sized 1–2% to profit from NVQLink adoption; use NVDA gains as liquidity to fund further quantum-specific option bets if NVQLink integrations with partners (e.g., Rigetti) are announced within 90 days.